CDSCO UID IMP/IVD/2023/000051_e97f5cc757ef294a8651351970ec7e5f_529c41615c6ba0e964c8f72905b72250

UREA U.V Kinetic Method

Wheecon Instruments Private Limited·Device Class Class B·India CDSCO·Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Registration details
UID
IMP/IVD/2023/000051_e97f5cc757ef294a8651351970ec7e5f_529c41615c6ba0e964c8f72905b72250
Device class
Class B
Brand name
BIOLABO ACID CALCIUM Arsenazo III Method
Approving authority
CDSCO
Product information
More than 90% of urea is excreted through the kidneys in urines. Measurement of the plasma or serum urea concentration is widely regarded as a test of renal function. However, a number of nonrenal factors also influence the circulating urea concentration: Urea increased level occurs when proteins catabolism is accelerated (BIOLABO ACID CALCIUM Arsenazo III Method). Urea is decreased in acute liver destruction and is accompanied with increased ammonium level. Urea level is generally studied in conjunction with creatinine level (BIOLABO ACID CALCIUM Arsenazo III Method) to refine the diagnosis of post-renal or pre-renal azotemia
Similar products (10)
Other products with the same name or brand
IRON Bathophenanthrolin(BIOLABO IRON Bathophenanthrolin)
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
LIPASE Kinetic Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
MAGNESIUM Calmagite
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
MICROALBUMIN Turbidimetric Immunoassay
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
ALT GPT Colorimetric Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
STONE ANALYSIS SET Chemical qualitative method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
URIC ACID Uricase method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
LDL-CHOLESTEROL Direct Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
TOTAL AND DIRECT BILIRUBIN Sulfanilic Acid Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
HDL-CHOLESTEROL Precipitant(BIOLABO HDL-CHOLESTEROL Precipitant)
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
Other products from Wheecon Instruments Private Limited
Products from the same license holder (10 products)
URYXXON 500
Brand: URYXXON 500
Class A
URYXXON Relax
Brand: URYXXON 500
Class A
IRON Bathophenanthrolin(BIOLABO IRON Bathophenanthrolin)
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
LIPASE Kinetic Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
MAGNESIUM Calmagite
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
MICROALBUMIN Turbidimetric Immunoassay
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
ALT GPT Colorimetric Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
STONE ANALYSIS SET Chemical qualitative method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
URIC ACID Uricase method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
LDL-CHOLESTEROL Direct Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
About this record

UREA U.V Kinetic Method is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_e97f5cc757ef294a8651351970ec7e5f_529c41615c6ba0e964c8f72905b72250. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.